JAMA Intern Med. Published online April 13, 2015. doi:10.1001/jamainternmed.2015.0747.

In this group of frail elderly women with osteoporosis, 1 dose of zoledronic acid improved BMD over 2 years. The clinical importance of nonsignificant increases in fracture and mortality rates in the treatment group needs further study. Since it is not known whether such therapy reduces the risk of fracture in this cohort, any change in nursing home practice must await results of larger trials powered to assess fracture rates.

Autor: Greenspan SL, Perera S, Ferchak M, Nace DA, Resnick NM.

Leave a Reply

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

  • cuatro + diecinueve =